Double Blind

In a double blind clinical trial, neither the patient nor the doctor is aware of who is receiving the treatment and who is receiving the inactive placebo until the trial is over. (When researchers know but participants do not, it’s called single blind.) Double blind trials are designed to prevent bias and to reduce the risk of outside factors unrelated to treatment influencing the trial’s results.